Tag: molecular diagnostics devices and equipment market analysis

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Molecular Diagnostics Devices And Equipment Market Set To Climb From $30.33 Billion In 2026 To $48.84 Billion By 2030

The market for molecular diagnostics devices and equipment has seen considerable expansion recently. This sector is expected to rise from $27.23 billion in 2025 to $30.33 billion in 2026, showing a compound annual growth rate (CAGR) of 11.4%. Historically, this growth can be linked to an increase in infectious disease testing, the widening scope of genetic screening programs, a surge in the application of molecular diagnostics in oncology, advancements in sequencing precision, and greater clinical recognition of molecular testing.

The molecular diagnostics devices and equipment market is anticipated to experience significant growth over the next few years. It is projected to reach $48.84 billion by 2030, advancing at a compound annual growth rate (CAGR) of 12.7%. This growth during the forecast period is fueled by increasing demand for personalized medicine, rising investments in genomic diagnostics, the expansion of decentralized molecular testing, growing adoption of automated sample processing, and a heightened focus on early-stage disease detection. Key trends during this period include the increasing adoption of PCR-based testing platforms, the rising use of next-generation sequencing technologies, growing integration of diagnostic software and bioinformatics, the expansion of companion diagnostics applications, and an enhanced focus on early and personalized diagnoses.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=93506836&type=smp&name=Molecular%20Diagnostics%20Devices%20And%20Equipment%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

Molecular Diagnostics Devices And Equipment Market Growth Factors Behind Sustained Expansion

The increasing prevalence of infectious diseases is anticipated to fuel the expansion of the molecular diagnostic devices and equipment market moving forward. Such diseases are defined as illnesses resulting from pathogenic microorganisms like bacteria, viruses, fungi, or parasites, which can spread between individuals or from animals to humans. The escalating frequency of infectious diseases is influenced by factors such as antimicrobial resistance, global interconnectedness and travel, urbanization, socioeconomic disparities, and an aging demographic. Molecular diagnostic tools and equipment are vital for the detection and management of these diseases. For instance, data from the Centers for Disease Control and Prevention, a US-based government agency, shows that tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, indicating an increase of 1,295 cases. Concurrently, the incidence rate climbed from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. Thus, the escalating incidence of infectious diseases is a key driver for the growth of the molecular diagnostic devices and equipment market.

Molecular Diagnostics Devices And Equipment Market Segment Outlook: Which Categories Are Growing Fastest?

The molecular diagnostics devices and equipment market covered in this report is segmented –

1) By Product: Instruments, Reagents And Consumables, Software

2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies

3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications

4) By End User: Diagnostic laboratories, Hospitals, Other End Users

Subsegments:

1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays

2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials

3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation

Molecular Diagnostics Devices And Equipment Market Industry Trends Fueling Future Revenue Growth

Leading companies in the molecular diagnostics devices and equipment market are developing innovative products, such as high-throughput sample-to-result instruments for molecular diagnostics. This high-throughput system will be founded on ELITech’s proven extraction and assay technology. It is designed to use the same reagents as InGenius and BeGenius. As an illustration, in April 2023, ELITechGroup, a France-based company involved in integrated in-vitro diagnostics, unveiled a high-throughput sample-to-result instrument for molecular diagnostics. This instrument facilitates continuous loading of samples and reagents, combined with true random-access capability. Users will have the flexibility to run different PCR reagents, protocols, and sample matrices simultaneously, offering maximum versatility.

Molecular Diagnostics Devices And Equipment Market Top Companies Driving Competitive Growth

Major companies operating in the molecular diagnostics devices and equipment market are F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di’an Diagnostics Technology Co. Ltd, Kindstar Global, BGI-Shenzhen, OriGene Technologies, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, TestLine, Hologic Inc., Illumina Inc., Cepheid Inc., Agilent Technologies Inc., AutoGenomics, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd

View The Full Molecular Diagnostics Devices And Equipment Market Report:

https://thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

Molecular Diagnostics Devices And Equipment Market Global Footprint: Which Region Leads The Market?

Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The molecular diagnostics devices and equipment market has witnessed significant expansion recently, driven by advances in technology and rising demand for precise medical testing. As diagnostics become more integral to personalized healthcare and disease management, the market is set to continue its robust growth trajectory. The following analysis delves into the market’s current size, growth drivers, segmentation, major players, and regional outlook.

Molecular Diagnostics Devices and Equipment Market Size and Projected Growth

In recent years, the molecular diagnostics devices and equipment market has experienced rapid growth. It is projected to increase from $27.23 billion in 2025 to $30.33 billion in 2026, representing a compound annual growth rate (CAGR) of 11.4%. This expansion during the historical period is largely attributed to the rise in infectious disease testing, broader genetic screening initiatives, increased use of molecular diagnostics in cancer care, enhanced sequencing accuracy, and greater clinical recognition of molecular testing’s value.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2595&type=smp

Looking ahead, the market is expected to accelerate, reaching $48.84 billion by 2030 with a CAGR of 12.7%. The forecast period’s growth factors include rising demand for personalized medicine, increased investments in genomic diagnostics, growth of decentralized molecular testing, wider adoption of automated sample processing technologies, and a stronger focus on early detection of diseases. Key trends shaping this future growth include expanded use of PCR-based testing, next-generation sequencing technologies, integrated diagnostic software and bioinformatics, companion diagnostics, and the push for early and individualized diagnosis.

Rising Infectious Disease Cases Fueling Molecular Diagnostics Market Expansion

One of the primary forces propelling growth in the molecular diagnostics devices and equipment market is the increasing prevalence of infectious diseases. These illnesses, caused by bacteria, viruses, fungi, or parasites, can spread from person to person or between animals and humans. Factors such as antimicrobial resistance, globalization and travel, urbanization, socioeconomic inequalities, and an aging population are contributing to the rise in infectious diseases worldwide.

Access The Complete Molecular Diagnostics Devices And Equipment Market Report:

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Molecular diagnostic tools play a crucial role in identifying and managing such infections. For example, data from the US Centers for Disease Control and Prevention shows that tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, with the incidence rate rising from 2.5 to 2.9 per 100,000 individuals. This growing burden of infectious diseases directly supports expanded demand for molecular diagnostic devices and equipment.

Breakdown of Molecular Diagnostics Devices and Equipment Market by Segment

The molecular diagnostics devices and equipment market is segmented based on various categories:

1) Product type including instruments, reagents and consumables, and software

2) Technology such as DNA sequencing, polymerase chain reaction (PCR), isothermal nucleic acid amplification technology, transcription mediated amplification (TMA), in situ hybridization, microarrays, mass spectrometry, and others

3) Application areas including cancer, pharmacogenomics, genetic testing, infectious diseases, prenatal diagnostics, and other uses

4) End users comprising diagnostic laboratories, hospitals, and other groups

Further subcategories include specific instruments like PCR machines, nucleic acid analyzers, DNA sequencers, and microarrays. Reagents and consumables cover PCR reagents, DNA probes and primers, sample preparation kits, and control materials. Software segments include data analysis programs, laboratory information management systems (LIMS), bioinformatics software, and integration software for instrumentation.

Innovations and Trends Shaping Future Prospects in Molecular Diagnostics

Leading companies in the molecular diagnostics field are innovating by developing high-throughput sample-to-result instruments that improve efficiency and versatility. These systems build on proven extraction and assay technologies, allowing continuous loading of samples and reagents with real random-access operations. Users can run multiple PCR reagents, protocols, and sample types simultaneously, enhancing flexibility.

For instance, in April 2023, ELITechGroup, a France-based in-vitro diagnostics company, launched such a high-throughput molecular diagnostics instrument. This product aims to streamline workflows and boost diagnostic capabilities, reflecting the broader industry trend of enhancing automation and scalability.

Top Players Competing in the Molecular Diagnostics Devices and Equipment Market

Several prominent companies are key players in this market, including F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di’an Diagnostics Technology Co. Ltd, Kindstar Global, BGI-Shenzhen, OriGene Technologies, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, TestLine, Hologic Inc., Illumina Inc., Cepheid Inc., Agilent Technologies Inc., AutoGenomics, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, and QIAGEN SA (Pty) Ltd. These companies lead innovation and competition through product development, strategic partnerships, and global reach.

Regional Analysis Reveals Asia-Pacific as a Key Market for Molecular Diagnostics

In 2025, Asia-Pacific was the largest market for molecular diagnostics devices and equipment worldwide. This region is also expected to register the fastest growth during the forecast period, driven by increasing healthcare investments, expanding diagnostic infrastructure, and a rising patient population. Other key geographic markets include South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, each contributing to the global outlook with varied growth dynamics and opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Expansion Is Expected For The Molecular Diagnostics Devices And Equipment Market Over The Forecast Period?

The market size for molecular diagnostics devices and equipment has witnessed rapid expansion in recent years. This market is set to increase from $27.23 billion in 2025 to $30.33 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.4%. The growth observed in the preceding period can be attributed to the rise in infectious disease testing, the broadening of genetic screening programs, the increasing application of molecular diagnostics in oncology, improvements in sequencing accuracy, and heightened clinical awareness of molecular testing.

The molecular diagnostics devices and equipment market size is anticipated to undergo significant growth in the coming years. It is projected to achieve a value of $48.84 billion by 2030, progressing at a compound annual growth rate (CAGR) of 12.7%. This expansion during the forecast period can be linked to increasing demand for personalized medicine, rising investments in genomic diagnostics, the broadening of decentralized molecular testing, growing adoption of automated sample processing, and an increasing focus on early-stage disease detection. Key trends in the forecast period include the increasing adoption of PCR-based testing platforms, rising use of next-generation sequencing technologies, growing integration of diagnostic software and bioinformatics, the expansion of companion diagnostics applications, and an enhanced focus on early and personalized diagnosis.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2595&type=smp

What Major Growth Factors Are Impacting The Molecular Diagnostics Devices And Equipment Market?

The increasing occurrence of infectious diseases is anticipated to drive the expansion of the molecular diagnostic devices and equipment market in the future. Such diseases are defined as conditions resulting from harmful microorganisms, including bacteria, viruses, fungi, or parasites, which possess the capability of spreading between people or from animals to humans. The growing frequency of infectious diseases stems from contributors like resistance to antimicrobials, increased global movement and tourism, urban expansion, differences in socioeconomic status, and a growing elderly demographic. Instruments and machinery for molecular diagnostics serve as crucial instruments for identifying and handling infectious diseases. As an illustration, data from the Centers for Disease Control and Prevention, a government body located in the US, indicates that tuberculosis cases climbed from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. Furthermore, the rate of incidence advanced from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. Consequently, the escalating occurrence of infectious diseases is fueling the expansion of the molecular diagnostic devices and equipment market.

Which Segment Divisions Form The Structure Of The Molecular Diagnostics Devices And Equipment Market?

The molecular diagnostics devices and equipment market covered in this report is segmented –

1) By Product: Instruments, Reagents And Consumables, Software

2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies

3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications

4) By End User: Diagnostic laboratories, Hospitals, Other End Users

Subsegments:

1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays

2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials

3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation

What Trends Are Influencing The Molecular Diagnostics Devices And Equipment Market Outlook?

Leading companies operating within the molecular diagnostics devices and equipment market are focused on developing innovative offerings, such as high-throughput sample-to-result instruments for molecular diagnostics. This high-throughput system will utilize ELITech’s proven extraction and assay technology and is designed to employ the same reagents as InGenius and BeGenius. For instance, in April 2023, ELITechGroup, a France-based company engaged in integrated in-vitro diagnostics, launched a high-throughput sample-to-result instrument for molecular diagnostics. This instrument supports continuous loading of samples and reagents, alongside true random-access capabilities. Users will be able to run different PCR reagents, protocols, and sample matrices simultaneously, ensuring maximum versatility.

Who Are The Prominent Players Across The Molecular Diagnostics Devices And Equipment Market?

Major companies operating in the molecular diagnostics devices and equipment market are F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di’an Diagnostics Technology Co. Ltd, Kindstar Global, BGI-Shenzhen, OriGene Technologies, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, TestLine, Hologic Inc., Illumina Inc., Cepheid Inc., Agilent Technologies Inc., AutoGenomics, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd

Access The Complete Molecular Diagnostics Devices And Equipment Market Report:

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

What Is The Largest Regional Market In The Molecular Diagnostics Devices And Equipment Market?

Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Molecular Diagnostics Devices And Equipment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Browse Through More Reports Similar to the Global Molecular Diagnostics Devices And Equipment Market 2026, By The Business Research Company

Dental Diagnostic Imaging Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/dental-diagnostic-imaging-devices-and-equipment-global-market-report

Point Of Care Molecular Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report

Microbiology Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Molecular Diagnostics Devices And Equipment Market Be By 2030 Compared To Its 2026 Market Size? _x000D_

The market for molecular diagnostics devices and equipment has seen rapid expansion in recent years. This market is set to increase from $27.23 billion in 2025 to $30.33 billion in 2026, registering a compound annual growth rate (CAGR) of 11.4%. Factors contributing to its historical growth include the rise in infectious disease testing, the broadening of genetic screening programs, an increase in the use of molecular diagnostics in oncology, enhancements in sequencing accuracy, and a greater clinical awareness of molecular testing._x000D_

_x000D_

The market for molecular diagnostics devices and equipment is projected to experience substantial growth over the coming years, anticipated to reach $48.84 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.7%. Factors driving this expansion during the forecast period include the rising demand for personalized medical treatments, increased investments in genomic diagnostic tools, the broadening of decentralized molecular testing, the growing acceptance of automated sample processing, and an intensified focus on identifying diseases at their early stages. Key trends expected over the forecast horizon involve the increasing uptake of PCR-based testing platforms, the growing utilization of next-generation sequencing technologies, the expanding integration of diagnostic software and bioinformatics, the broadening of companion diagnostics applications, and a heightened emphasis on early and customized diagnoses._x000D_

_x000D_

#Access Your Free Sample Report For In-Depth Market Analysis:#_x000D_

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report_x000D_

_x000D_

Which Key Factors Are Driving The Molecular Diagnostics Devices And Equipment Market Growth?_x000D_

The expansion of the molecular diagnostic devices and equipment market is anticipated to be fueled by the increasing occurrence of infectious diseases. These diseases are defined as ailments resulting from pathogenic microorganisms like bacteria, viruses, fungi, or parasites, capable of spreading between individuals or from animals to humans. The growing prevalence of infectious diseases is influenced by factors such as antimicrobial resistance, globalization and travel, urbanization, socioeconomic disparities, and an aging population. Molecular diagnostic tools and equipment are crucial for the identification and management of infectious diseases. For example, according to the Centers for Disease Control and Prevention, a US-based government agency, tuberculosis cases climbed from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. Additionally, the incidence rate rose from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. Therefore, the rising incidence of infectious diseases is a key driver for the growth of the molecular diagnostic devices and equipment market._x000D_

_x000D_

How Are Segments Identified Within The Molecular Diagnostics Devices And Equipment Market Segment Framework?_x000D_

The molecular diagnostics devices and equipment market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Instruments, Reagents And Consumables, Software _x000D_

2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies_x000D_

3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications_x000D_

4) By End User: Diagnostic laboratories, Hospitals, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays _x000D_

2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials _x000D_

3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation _x000D_

_x000D_

Which Trends Are Guiding The Direction Of The Molecular Diagnostics Devices And Equipment Market?_x000D_

Leading companies in the molecular diagnostics devices and equipment market are developing innovative products like high-throughput sample-to-result instruments for molecular diagnostics. These high-throughput systems will be founded upon ELITech’s established extraction and assay technology and will employ the same reagents as InGenius and BeGenius. Illustratively, in April 2023, ELITechGroup, a France-based entity involved in integrated in-vitro diagnostics, unveiled a high-throughput sample-to-result instrument for molecular diagnostics. This device facilitates continuous loading of samples and reagents alongside true random-access capability. Users will have the capacity to process diverse PCR reagents, protocols, and sample matrices simultaneously, offering maximum versatility._x000D_

_x000D_

Who Are The Companies Competing Within The Molecular Diagnostics Devices And Equipment Market?_x000D_

Major companies operating in the molecular diagnostics devices and equipment market are F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di’an Diagnostics Technology Co. Ltd, Kindstar Global, BGI-Shenzhen, OriGene Technologies, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, TestLine, Hologic Inc., Illumina Inc., Cepheid Inc., Agilent Technologies Inc., AutoGenomics, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd _x000D_

_x000D_

#Get The Full Molecular Diagnostics Devices And Equipment Market Report:#_x000D_

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report_x000D_

_x000D_

Which Region Has The Greatest Market Share In The Molecular Diagnostics Devices And Equipment Market?_x000D_

Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request A Customized Molecular Diagnostics Devices And Equipment Market Report For Competitive Insights:#_x000D_

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Molecular Diagnostics Devices And Equipment Market 2026, By The Business Research Company#_x000D_

_x000D_

Dental Diagnostic Imaging Devices And Equipment Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/dental-diagnostic-imaging-devices-and-equipment-global-market-report_x000D_

_x000D_

Point Of Care Molecular Diagnostics Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report_x000D_

_x000D_

Microbiology Diagnostic Devices And Equipment Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report_x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Molecular Diagnostics Devices And Equipment Market Be By 2030 Compared To Its 2026 Market Size?

The market for molecular diagnostics devices and equipment has seen rapid expansion in recent years. This market is set to increase from $27.23 billion in 2025 to $30.33 billion in 2026, registering a compound annual growth rate (CAGR) of 11.4%. Factors contributing to its historical growth include the rise in infectious disease testing, the broadening of genetic screening programs, an increase in the use of molecular diagnostics in oncology, enhancements in sequencing accuracy, and a greater clinical awareness of molecular testing.

The market for molecular diagnostics devices and equipment is projected to experience substantial growth over the coming years, anticipated to reach $48.84 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.7%. Factors driving this expansion during the forecast period include the rising demand for personalized medical treatments, increased investments in genomic diagnostic tools, the broadening of decentralized molecular testing, the growing acceptance of automated sample processing, and an intensified focus on identifying diseases at their early stages. Key trends expected over the forecast horizon involve the increasing uptake of PCR-based testing platforms, the growing utilization of next-generation sequencing technologies, the expanding integration of diagnostic software and bioinformatics, the broadening of companion diagnostics applications, and a heightened emphasis on early and customized diagnoses.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Which Key Factors Are Driving The Molecular Diagnostics Devices And Equipment Market Growth?

The expansion of the molecular diagnostic devices and equipment market is anticipated to be fueled by the increasing occurrence of infectious diseases. These diseases are defined as ailments resulting from pathogenic microorganisms like bacteria, viruses, fungi, or parasites, capable of spreading between individuals or from animals to humans. The growing prevalence of infectious diseases is influenced by factors such as antimicrobial resistance, globalization and travel, urbanization, socioeconomic disparities, and an aging population. Molecular diagnostic tools and equipment are crucial for the identification and management of infectious diseases. For example, according to the Centers for Disease Control and Prevention, a US-based government agency, tuberculosis cases climbed from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. Additionally, the incidence rate rose from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. Therefore, the rising incidence of infectious diseases is a key driver for the growth of the molecular diagnostic devices and equipment market.

How Are Segments Identified Within The Molecular Diagnostics Devices And Equipment Market Segment Framework?

The molecular diagnostics devices and equipment market covered in this report is segmented –

1) By Product: Instruments, Reagents And Consumables, Software

2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies

3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications

4) By End User: Diagnostic laboratories, Hospitals, Other End Users

Subsegments:

1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays

2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials

3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation

Which Trends Are Guiding The Direction Of The Molecular Diagnostics Devices And Equipment Market?

Leading companies in the molecular diagnostics devices and equipment market are developing innovative products like high-throughput sample-to-result instruments for molecular diagnostics. These high-throughput systems will be founded upon ELITech’s established extraction and assay technology and will employ the same reagents as InGenius and BeGenius. Illustratively, in April 2023, ELITechGroup, a France-based entity involved in integrated in-vitro diagnostics, unveiled a high-throughput sample-to-result instrument for molecular diagnostics. This device facilitates continuous loading of samples and reagents alongside true random-access capability. Users will have the capacity to process diverse PCR reagents, protocols, and sample matrices simultaneously, offering maximum versatility.

Who Are The Companies Competing Within The Molecular Diagnostics Devices And Equipment Market?

Major companies operating in the molecular diagnostics devices and equipment market are F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di’an Diagnostics Technology Co. Ltd, Kindstar Global, BGI-Shenzhen, OriGene Technologies, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, TestLine, Hologic Inc., Illumina Inc., Cepheid Inc., Agilent Technologies Inc., AutoGenomics, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd

Get The Full Molecular Diagnostics Devices And Equipment Market Report:

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Which Region Has The Greatest Market Share In The Molecular Diagnostics Devices And Equipment Market?

Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Molecular Diagnostics Devices And Equipment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Browse Through More Reports Similar to the Global Molecular Diagnostics Devices And Equipment Market 2026, By The Business Research Company

Dental Diagnostic Imaging Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/dental-diagnostic-imaging-devices-and-equipment-global-market-report

Point Of Care Molecular Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report

Microbiology Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Molecular Diagnostics Devices And Equipment Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The molecular diagnostics devices and equipment market size has experienced significant expansion in recent years. It is projected to increase from $27.23 billion in 2025 to $30.33 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.4%. The market’s historical growth can be attributed to growth in infectious disease testing, expansion of genetic screening programs, rising use of molecular diagnostics in oncology, improvements in sequencing accuracy, and increased clinical awareness of molecular testing.

The molecular diagnostics devices and equipment market is projected to experience swift expansion in the coming years. It will grow to $48.84 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. This anticipated growth during the forecast period can be attributed to factors such as an escalating demand for personalized medicine, greater investments in genomic diagnostics, the broadening scope of decentralized molecular testing, the increasing integration of automated sample processing, and a heightened emphasis on detecting diseases at an early stage. Key trends for the forecast period encompass a wider embrace of PCR-based testing platforms, an increase in the utilization of next-generation sequencing technologies, the expanding incorporation of diagnostic software and bioinformatics, the broadening of companion diagnostics applications, and an intensified focus on early and personalized diagnoses.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2595&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Molecular Diagnostics Devices And Equipment Market?

The escalating occurrence of infectious diseases is set to drive the expansion of the molecular diagnostic devices and equipment market moving forward. These illnesses are defined as conditions caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, which possess the ability to transfer between individuals or from animals to humans. Factors such as antimicrobial resistance, increased globalization and travel, urbanization, socioeconomic disparities, and an aging population are contributing to this rise in infectious disease incidence. Molecular diagnostic devices and equipment serve as crucial tools in both the detection and management of these diseases. For example, according to the Centers for Disease Control and Prevention, a US-based government agency, the volume of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing an increment of 1,295 cases. Moreover, the incidence rate rose from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. This upward trend in infectious disease cases is thus propelling the growth of the molecular diagnostic devices and equipment market.

What Major Segment Divisions Exist Within The Molecular Diagnostics Devices And Equipment Market?

The molecular diagnostics devices and equipment market covered in this report is segmented –

1) By Product: Instruments, Reagents And Consumables, Software

2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies

3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications

4) By End User: Diagnostic laboratories, Hospitals, Other End Users

Subsegments:

1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays

2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials

3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation

How Are Trends Shaping The Direction Of The Molecular Diagnostics Devices And Equipment Market?

Leading firms within the molecular diagnostics devices and equipment market are creating advanced products, specifically high-throughput sample-to-result instruments for molecular diagnostics. These high-throughput systems will utilize ELITech’s established extraction and assay technology and be compatible with the reagents used by InGenius and BeGenius. An example of this is ELITechGroup, a France-based integrated in-vitro diagnostics company, which introduced a high-throughput sample-to-result instrument for molecular diagnostics in April 2023. This device allows for ongoing loading of samples and reagents along with true random-access functionality. Users will have the flexibility to simultaneously execute various PCR reagents, protocols, and sample matrices.

Which Companies Are Leading Innovation In The Molecular Diagnostics Devices And Equipment Market?

Major companies operating in the molecular diagnostics devices and equipment market are F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di’an Diagnostics Technology Co. Ltd, Kindstar Global, BGI-Shenzhen, OriGene Technologies, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, TestLine, Hologic Inc., Illumina Inc., Cepheid Inc., Agilent Technologies Inc., AutoGenomics, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd

Read the full molecular diagnostics devices and equipment market report here:

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

What Are The Leading Geographic Regions In The Molecular Diagnostics Devices And Equipment Market?

Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Molecular Diagnostics Devices And Equipment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2595&type=smp

Browse Through More Reports Similar to the Global Molecular Diagnostics Devices And Equipment Market 2026, By The Business Research Company

Dental Diagnostic Imaging Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/dental-diagnostic-imaging-devices-and-equipment-global-market-report

Point Of Care Molecular Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report

Microbiology Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Molecular Diagnostics Devices And Equipment Market between 2026 and 2030?

The molecular diagnostics devices and equipment market size has seen rapid expansion in recent years. It is projected to increase from $27.23 billion in 2025 to $30.33 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.4%. The historical growth in this market can be linked to factors such as an increase in infectious disease testing, the broadening of genetic screening programs, a rise in the application of molecular diagnostics in oncology, enhancements in sequencing accuracy, and heightened clinical awareness of molecular testing.

The molecular diagnostics devices and equipment market size is projected to experience substantial growth in the coming years, with expectations to reach $48.84 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. This anticipated expansion during the forecast period is largely due to factors such as the increasing demand for personalized medicine, greater investments in genomic diagnostics, the broadening of decentralized molecular testing, the rising adoption of automated sample processing, and a heightened emphasis on early-stage disease detection. Significant trends during this period involve the increasing uptake of PCR-based testing platforms, the rising utilization of next-generation sequencing technologies, the expanding integration of diagnostic software and bioinformatics, the growth of companion diagnostics applications, and an enhanced focus on early and personalized diagnosis.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2595&type=smp

Which Drivers Are Expected To Impact The Molecular Diagnostics Devices And Equipment Market During The Forecast Period?

The increasing occurrence of infectious diseases is anticipated to drive the expansion of the molecular diagnostic devices and equipment market in the future. These diseases are defined as ailments resulting from pathogenic microorganisms like bacteria, viruses, fungi, or parasites, capable of spreading between individuals or from animals to humans. The growing prevalence of infectious diseases stems from various factors, including antimicrobial resistance, increased globalization and travel, urbanization, socioeconomic inequalities, and a demographic shift towards an older population. Crucially, molecular diagnostic devices and equipment serve as vital instruments for identifying and managing infectious diseases. As an illustration, data from the Centers for Disease Control and Prevention, a US-based government agency, shows that tuberculosis cases climbed from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. Furthermore, the incidence rate advanced from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. Consequently, the escalating incidence of infectious diseases is propelling the expansion of the molecular diagnostic devices and equipment market.

How Is The Molecular Diagnostics Devices And Equipment Market Divided Into Segments?

The molecular diagnostics devices and equipment market covered in this report is segmented –

1) By Product: Instruments, Reagents And Consumables, Software

2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies

3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications

4) By End User: Diagnostic laboratories, Hospitals, Other End Users

Subsegments:

1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays

2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials

3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation

How Are New Market Trends Shaping The Landscape Of The Molecular Diagnostics Devices And Equipment Market?

Leading companies in the molecular diagnostics devices and equipment market are actively developing innovative products, such as high-throughput sample-to-result instruments for molecular diagnostics. This high-throughput system will be built upon ELITech’s proven extraction and assay technology, and it will utilize the same reagents as InGenius and BeGenius. For example, in April 2023, ELITechGroup, a France-based company focused on integrated in-vitro diagnostics, launched a high-throughput sample-to-result instrument specifically for molecular diagnostics. This instrument allows for continuous loading of samples and reagents, combined with true random-access capabilities, enabling users to run diverse PCR reagents, protocols, and sample matrices in parallel with high versatility.

Which Leading Companies Dominate The Molecular Diagnostics Devices And Equipment Market Share?

Major companies operating in the molecular diagnostics devices and equipment market are F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di’an Diagnostics Technology Co. Ltd, Kindstar Global, BGI-Shenzhen, OriGene Technologies, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, TestLine, Hologic Inc., Illumina Inc., Cepheid Inc., Agilent Technologies Inc., AutoGenomics, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Molecular Diagnostics Devices And Equipment Market?

Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Molecular Diagnostics Devices And Equipment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2595&type=smp

Browse Through More Reports Similar to the Global Molecular Diagnostics Devices And Equipment Market 2026, By The Business Research Company

Dental Diagnostic Imaging Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dental-diagnostic-imaging-devices-and-equipment-global-market-report

Point Of Care Molecular Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report

Microbiology Diagnostic Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the molecular diagnostics devices and equipment market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Molecular Diagnostics Devices And Equipment Market And What Value Is Projected For 2029?

The molecular diagnostics devices and equipment market has experienced substantial growth in recent years. This market is projected to expand from $24.4 billion in 2024 to $27.23 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.6%. The expansion observed in the past can be attributed to a rise in funding, increased healthcare expenditure, economic growth in emerging markets, rapid technological advances, the appearance of novel pathogenic infestations, and a quickly growing geriatric population.

The market for molecular diagnostics devices and equipment is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $42.59 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.8%. Key factors contributing to this projected growth include the swift increase in bacterial and viral epidemics, an aging global demographic, enhanced access to healthcare services, the growing incidence of chronic ailments, and the surge in demand for molecular diagnostic devices and equipment prompted by COVID-19. Noteworthy trends expected during this period encompass the integration of automation into molecular diagnostics, the application of artificial intelligence, a heightened need for molecular diagnostic tools in researching rare conditions, the expanding acceptance of big data, the implementation of next-generation sequencing for newborn screenings, and the development of point-of-care molecular diagnostics (POC mdx).

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2595&type=smp

What Factors Are Boosting The Molecular Diagnostics Devices And Equipment Market?

The growing occurrence of infectious diseases is projected to boost the expansion of the molecular diagnostic devices and equipment market in the future. Infectious diseases are defined as ailments resulting from pathogenic microorganisms, including bacteria, viruses, fungi, or parasites, which possess the capability of transmission between individuals or from animals to people. The increasing frequency of infectious diseases stems from contributors like antimicrobial resistance, global mobility and travel, urban development, differences in socioeconomic status, and an aging demographic. Critical instruments for identifying and managing infectious diseases include molecular diagnostic devices and equipment. As an illustration, data from the Office for National Statistics, a UK-based government body, indicated that for the week concluding 17 March 2023, the UK registered 619 deaths linked to COVID-19, an increase from 605 in the preceding week. In the same week, fatalities due to COVID-19 constituted 4.5% of total deaths in the UK, a minor reduction from 4.6% observed the week prior. Consequently, the escalating incidence of infectious diseases is fueling the expansion of the molecular diagnostic devices and equipment market.

What Are The Core Segmentation Criteria In The Molecular Diagnostics Devices And Equipment Market?

The molecular diagnostics devices and equipmentmarket covered in this report is segmented –

1) By Product: Instruments, Reagents And Consumables, Software

2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies

3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications

4) By End User: Diagnostic laboratories, Hospitals, Other End Users

Subsegments:

1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays

2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials

3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation

Which Emerging Trends Are Reshaping The Molecular Diagnostics Devices And Equipment Market Landscape?

Leading entities within the molecular diagnostic sector are concentrating on creating automated systems for the instrumentation and machinery involved in molecular diagnostic procedures. Automating these procedures is expected to boost the overall diagnostic process’s productivity and uniformity. Computerized diagnostic methods yield dependable and effective test outcomes, surpassing those achieved through manual testing by various specialists. Prominent industry participants are employing the nanotechnology-driven Oral Fluid Nano Sensor Test (OFNASET). This particular test utilizes a microfluidic nanosensor to identify oral cancer biomarkers present in saliva. Aligning with the ongoing emphasis on automation and precision, Roche developed cobas connection modules (CCM) to enhance scalability and the smooth movement of samples, enabling their automatic transfer across various systems and instruments. This effectively establishes a completely automated operational flow.

Which Players Are Shaping The Competitive Landscape Of The Molecular Diagnostics Devices And EquipmentXX Market?

Major companies operating in the molecular diagnostics devices and equipment market include F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di’an Diagnostics Technology Co. Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, BGI-Shenzhen, OriGene Technologies, Bayer AG, Johnson & Johnson, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, Interlabservis, GeneMe, TestLine, Clinical Diagnostics s.r.o, Hologic Inc., Illumina Inc., Novartis AG, Cepheid Inc., Admera Health, Agilent technologies Inc., AutoGenomics, Bio-Red Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

What Regional Trends Are Shaping Growth In The Molecular Diagnostics Devices And Equipment Market?

Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2024. Western Europe was the second largest market in molecular diagnostics devices (or) equipment market. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=2595&type=smp

Browse Through More Reports Similar to the Global Molecular Diagnostics Devices And Equipment Market 2025, By The Business Research Company

Diagnostic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diagnostic-equipment-global-market-report

Diagnostic Imaging Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diagnostic-imaging-equipment-global-market-report

Point Of Care Diagnostics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Molecular Diagnostics Devices And Equipment Market From 2025 To 2034?

The sector encompassing molecular diagnostics apparatus and machinery has experienced a swift expansion lately. Projections indicate this market will ascend from a valuation of $24.4 billion in 2024 to $27.23 billion the following year, exhibiting an 11.6% compound annual growth rate. A surge in financial backing, escalating healthcare spending, burgeoning economies in developing territories, swift technological innovation, the appearance of new infectious agents, and the quick aging of the population are factors credited with fueling this growth trajectory during the past period.

Anticipation is high for the swift expansion of the molecular diagnostics apparatus and instrumentation market, projected to reach a valuation of $42.59 billion come 2029, exhibiting a compound annual growth rate (CAGR) of 11.8% throughout the ensuing years. This upward trajectory throughout the projection timeframe stems from several key factors: a marked proliferation in diverse bacterial and viral outbreaks, the demographic shift toward an older populace, wider availability of medical services, the increasing incidence of long-term ailments, alongside heightened consumer desire for molecular diagnostic tools and apparatus spurred by the COVID-19 pandemic experience. Key developments shaping this market over the forecast period encompass the incorporation of automated processes within molecular diagnostics practices, the integration of artificial intelligence technologies, escalating requirements for these diagnostic instruments in the investigation of infrequently occurring illnesses, broader uptake of big data analytics, the implementation of next-generation sequencing methods for screening newborns, and the growing preference for point-of-care molecular diagnostics (POC mdx) solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2595&type=smp

What Are The Drivers Pushing New Developments In The Molecular Diagnostics Devices And Equipment Market?

An increasing prevalence of illnesses caused by pathogens such as viruses, bacteria, parasites, or fungi, which spread between people or from animals to humans, is anticipated to accelerate the expansion of the market for molecular diagnostic apparatus and machinery. This surge in infectious disease occurrence is fueled by several elements, including the development of resistance to antimicrobials, heightened global interconnectedness and movement across borders, increased population density in cities, variations in wealth and social standing, and an increasing proportion of elderly individuals in the population. Since molecular diagnostic instrumentation plays a crucial role in identifying and overseeing these transmissible ailments, its demand is rising; for example, statistics from the UK’s Office for National Statistics showed that in the seven-day period ending March 17, 2023, the United Kingdom registered 619 fatalities attributed to COVID-19, an increase from the 605 recorded the preceding week, with this figure accounting for 4.5 percent of total UK deaths during that specific week, a minor dip from the 4.6 percent noted the week before, thus illustrating how the escalation of contagious diseases fuels the progression of the market for molecular diagnostic equipment.

What Are The Major Segments Identified In The Molecular Diagnostics Devices And Equipment Market?

The molecular diagnostics devices and equipmentmarket covered in this report is segmented –

1) By Product: Instruments, Reagents And Consumables, Software

2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies

3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications

4) By End User: Diagnostic laboratories, Hospitals, Other End Users

Subsegments:

1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays

2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials

3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation

What Trends Are Redefining The Molecular Diagnostics Devices And Equipment Market Dynamics?

Leading companies within the molecular diagnostics sector are heavily prioritizing the creation of self-regulating systems for the machinery and apparatus integral to molecular testing procedures; this mechanization is intended to boost both the output and the reproducibility across the entire spectrum of diagnostics, yielding highly dependable and effective outcomes surpassing those obtained through human-executed analyses. Prominent industry participants are currently employing nanotechnology-derived Oral Fluid Nano Sensor Tests (OFNASET), which leverage nanosensors operating on microfluidic principles to identify cancer indicators present in saliva. In alignment with the drive towards increased automation and precision, Roche introduced its cobas connection modules (CCM), enhancements designed to optimize the ability to scale operations and streamline how samples move, facilitating automatic transfer between various analytical instruments and thereby establishing a completely autonomous operational sequence.

Which Global Market Leaders Are Shaping The Future Of The Molecular Diagnostics Devices And Equipment Sector?

Major companies operating in the molecular diagnostics devices and equipment market include F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di’an Diagnostics Technology Co. Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, BGI-Shenzhen, OriGene Technologies, Bayer AG, Johnson & Johnson, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, Interlabservis, GeneMe, TestLine, Clinical Diagnostics s.r.o, Hologic Inc., Illumina Inc., Novartis AG, Cepheid Inc., Admera Health, Agilent technologies Inc., AutoGenomics, Bio-Red Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Which Regional Markets Are Contributing Most To The Molecular Diagnostics Devices And Equipment Industry Expansion?

Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2024. Western Europe was the second largest market in molecular diagnostics devices (or) equipment market. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Molecular Diagnostics Devices And Equipment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=2595&type=smp

Browse Through More Reports Similar to the Global Molecular Diagnostics Devices And Equipment Market 2025, By The Business Research Company

Diagnostic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diagnostic-equipment-global-market-report

Diagnostic Imaging Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diagnostic-imaging-equipment-global-market-report

Point Of Care Diagnostics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Milestones in the Molecular Diagnostics Devices And Equipment Market’s Growth Trajectory From 2025 To 2034?

The market for molecular diagnostics devices and equipment has witnessed a swift expansion in recent years. The market size, which stood at $24.4 billion in 2024, is projected to climb to $27.23 billion in 2025, with a compound annual growth rate (CAGR) of 11.6%. Factors contributing to the growth experienced in the historic period include enhanced funding, escalated healthcare spending, economic progression in emerging markets, quick technological developments, the emergence of new pathogenic infestations, and a rapidly rising elderly population.

The market size for molecular diagnostics devices and equipment is predicted to undergo swift expansion in the coming years, escalating to $42.59 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 11.8%. The forecast period’s growth can be tied to the quick proliferation of several bacterial and viral epidemics, an aging population, expanded healthcare accessibility, a surge in chronic diseases prevalence, and a heightened need for molecular diagnostic devices and equipment due to COVID-19. Major trends during the forecast period encompass automation in molecular diagnostics, the implementation of artificial intelligence, amplified need for molecular diagnostic devices for studying rare diseases, burgeoning adoption of big data, utilization of next-generation sequencing for newborn screening, and incorporation of point-of-care molecular diagnostics (POC mdx).

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2595&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Molecular Diagnostics Devices And Equipment Market?

The increase in infectious diseases is anticipated to fuel the expansion of the molecular diagnostic devices and equipment market in the future. Illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread from one person to another or from animals to humans constitute infectious diseases. The increase in infectious diseases is driven by factors like resistance to antimicrobial agents, globalization and travel, urban development, socioeconomic inequalities, and an aging population. Molecular diagnostic tools and equipment play a crucial role in identifying and controlling infectious diseases. For example, in March 2023, the Office for National Statistics, a governmental department in the UK, reported that in the week ending March 17, 2023, the UK noted 619 COVID-19-related fatalities, a rise from 605 the previous week. During that week, COVID-19 deaths accounted for 4.5% of all deaths in the UK, slightly lower than the previous week’s 4.6%. As such, the increasing prevalence of infectious diseases is propelling the growth of the molecular diagnostic devices and equipment market.

Which Primary Segments of the Molecular Diagnostics Devices And Equipment Market Are Driving Growth and Industry Transformations?

The molecular diagnostics devices and equipmentmarket covered in this report is segmented –

1) By Product: Instruments, Reagents And Consumables, Software

2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies

3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications

4) By End User: Diagnostic laboratories, Hospitals, Other End Users

Subsegments:

1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays

2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials

3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2595&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Molecular Diagnostics Devices And Equipment Market?# Market?

Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2024. Western Europe was the second largest market in molecular diagnostics devices (or) equipment market. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Most Significant Market Trends in the Molecular Diagnostics Devices And Equipment Market?

Prominent companies in the molecular diagnostic market are investing in the development of automated solutions for devices and tools used in molecular diagnostic procedures. The automation is aimed to boost the productivity and uniformity of the entire diagnostic procedure. Shifting to digital diagnostics offers reliable and proficient test results which are not often achieved with manual testing. Leading companies in the sector are adopting the use of nanotechnology-based Oral Fluid Nano Sensor Test (OFNASET). This test leverages a microfluidic-based nanosensor to identify oral cancer biomarkers in saliva. In response to the automation and precision trend, Roche developed cobas connection modules (CCM) to enhance scalability and the efficiency of sample-flow, enabling samples to seamlessly transition between various systems and devices. This has led to the creation of a fully automated workflow.

View the full report here:

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

What Parameters Are Used to Define the Molecular Diagnostics Devices And Equipment Market?

Molecular diagnostics devices are used to diagnose infectious diseases and perform screening by detecting specific sequences in DNA or RNA. It helps doctors prescribe more accurate therapeutic interventions in the early stages of a disease.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2595

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model